Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 1066 AL 1080

A mir-153 binding site variation in SNCA in a patient with Parkinson's disease

Kim HJ, Park G, Jeon BS, Park WY, Kim YE.

Mov Disord. 2013 Oct;28(12):1755-6. doi: 10.1002/mds.25505. Epub 2013 May 14.

Validation of the Mayo Sleep Questionnaire to screen for REM sleep behavior disorder in a community-based sample

Boeve BF, Molano JR, Ferman TJ, Lin SC, Bieniek K, Tippmann-Peikert M, Boot B, St Louis EK, Knopman DS, Petersen RC, Silber MH.

J Clin Sleep Med. 2013 May 15;9(5):475-80. doi: 10.5664/jcsm.2670.

Predictive in silico studies of human 5-hydroxytryptamine receptor subtype 2B (5-HT2B) and valvular heart disease

Reid TE, Kumar K, Wang XS.

Curr Top Med Chem. 2013;13(11):1353-62. doi: 10.2174/15680266113139990039.

Mutations in GBA and risk of Parkinson's disease: a meta-analysis based on 25 case-control studies

Mao X, Wang T, Peng R, Chang X, Li N, Gu Y, Zhao D, Liao Q, Liu M.

Neurol Res. 2013 Oct;35(8):873-8. doi: 10.1179/1743132813Y.0000000224. Epub 2013 May 14.

Radiofrequency catheter ablation of the accessory pathway adversely affected the left ventricular outflow tract pressure gradient in a patient with hypertrophic obstructive cardiomyopathy

Nakayama A, Takahashi M, Hina K, Fujiu K, Sugiyama H, Kojima T, Ando J, Imai Y, Hirata Y, Nagai R.

Int Heart J. 2013;54(2):111-4. doi: 10.1536/ihj.54.111.

Crack cocaine use due to dopamine agonist therapy in Parkinson disease

Friedman JH, Chang V.

Neurology. 2013 Jun 11;80(24):2269-70. doi: 10.1212/WNL.0b013e318296e9d5. Epub 2013 May 15.

Neurological applications for myocardial MIBG scintigraphy

Lucio CG, Vincenzo C, Antonio R, Oscar T, Antonio R, Luigi M.

Nucl Med Rev Cent East Eur. 2013;16(1):35-41. doi: 10.5603/NMR.2013.0007.

Diagnosis of drug-induced parkinsonism: can transcranial sonography make the difference?

Poewe W, Seppi K.

Eur J Neurol. 2013 Nov;20(11):1429-30. doi: 10.1111/ene.12189. Epub 2013 May 17.

Delusional misidentification syndrome and other unusual delusions in advanced Parkinson's disease

Moro A, Munhoz RP, Moscovich M, Arruda WO, Teive HA.

Parkinsonism Relat Disord. 2013 Aug;19(8):751-4. doi: 10.1016/j.parkreldis.2013.04.021. Epub 2013 May 14.

Neuropsychiatric symptoms in patients with dementias associated with cortical Lewy bodies: pathophysiology, clinical features, and pharmacological management

Ballard C, Aarsland D, Francis P, Corbett A.

Drugs Aging. 2013 Aug;30(8):603-11. doi: 10.1007/s40266-013-0092-x.

Progress in stem cell therapy for major human neurological disorders

Martínez-Morales PL, Revilla A, Ocaña I, González C, Sainz P, McGuire D, Liste I.

Stem Cell Rev Rep. 2013 Oct;9(5):685-99. doi: 10.1007/s12015-013-9443-6.

Blocking LINGO-1 as a therapy to promote CNS repair: from concept to the clinic

Mi S, Pepinsky RB, Cadavid D.

CNS Drugs. 2013 Jul;27(7):493-503. doi: 10.1007/s40263-013-0068-8.

Dysfunction of the autophagy/lysosomal degradation pathway is a shared feature of the genetic synucleinopathies

Manzoni C, Lewis PA.

FASEB J. 2013 Sep;27(9):3424-9. doi: 10.1096/fj.12-223842. Epub 2013 May 16.

Removing the blinkers: moving beyond striatal dopamine in Parkinson's disease

Eskow Jaunarajs KL, Standaert DG.

J Neurochem. 2013 Jun;125(5):639-41. doi: 10.1111/jnc.12167.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias